Rapid Liver Deterioration Following IV Cocaine Injection
Intravenous cocaine can cause severe acute liver injury through multiple mechanisms including direct hepatotoxicity, hyperthermia-induced damage, and ischemic injury from profound hypotension, with mortality rates reaching 44% in patients who develop severe hepatic dysfunction (ALT >400 U/L). 1
Clinical Presentation and Risk Stratification
The severity of liver injury following IV cocaine use correlates directly with systemic complications and mortality risk. Patients presenting with acute cocaine intoxication should be immediately stratified based on ALT levels:
- Severe liver injury (ALT >400 U/L): Associated with 44% mortality and high risk of multiorgan failure 1
- Moderate injury (ALT 36-399 U/L): Lower risk but requires close monitoring
- No injury (normal ALT): Better prognosis but not risk-free
High-Risk Clinical Features
Patients with severe cocaine-induced liver injury (ALT >400 U/L) demonstrate significantly worse outcomes when accompanied by 1:
- Profound hypotension (44% vs 0% in normal ALT group, p<0.025)
- Disseminated intravascular coagulation (50% vs 0%, p<0.005)
- Hyperpyrexia (75% vs 25%, p<0.025)
- Acute renal failure (81% vs 0%, p<0.001)
- Rhabdomyolysis (present in 59% of cases with hepatic dysfunction) 1
Histologically, expect centrilobular and midzonal necrosis progressing to panlobular necrosis in fatal cases, with mild lymphocytic infiltrate and bile duct proliferation 1.
Immediate Management Algorithm
1. Initial Assessment and Monitoring
Do not wait for symptoms to worsen. Obtain immediately:
- Prothrombin time/INR - critical for assessing synthetic function 2
- AST, ALT, alkaline phosphatase, total bilirubin, albumin 2
- Arterial blood gas and lactate - assess tissue perfusion 2
- Creatinine, BUN - evaluate for concurrent renal injury 2
- Creatine kinase - screen for rhabdomyolysis 1
- Toxicology screen with cocaine levels 3
- Coagulation panel - assess for DIC 1
2. Hepatic-Specific Interventions
Administer N-acetylcysteine (NAC) immediately, even without acetaminophen co-ingestion. 4 While the FDA label notes cocaine is not recommended in patients with hepatic impairment 5, this refers to therapeutic use—for acute toxicity, NAC has shown benefit in cocaine-induced liver injury 4.
NAC dosing (IV route preferred in acute setting):
- Loading: 150 mg/kg in 5% dextrose over 15 minutes
- Maintenance: 50 mg/kg over 4 hours, then 100 mg/kg over 16 hours 2
3. Cardiovascular Stabilization
Avoid pure beta-blockers - they can worsen cocaine-induced vasospasm through unopposed alpha-adrenergic stimulation 6. Instead:
- First-line: Benzodiazepines (lorazepam 2-4 mg IV) for agitation, tachycardia, and hypertension 6
- Second-line for persistent hypertension: Combined β/α-blockers (labetalol, carvedilol) - no adverse events reported and effective for both tachycardia and hypertension 6
- For coronary vasospasm: Calcium channel blockers (verapamil, diltiazem) or nitroglycerin, though nitroglycerin carries risk of severe hypotension and reflex tachycardia 6
4. Critical Care Considerations
Transfer to ICU immediately if 2:
- ALT >400 U/L
- Any signs of encephalopathy
- INR >1.5
- Hypotension requiring pressors
- Evidence of DIC or acute renal failure
Contact transplant center early 2, though polysubstance abuse may complicate transplant candidacy 7. For non-transplant candidates with fulminant hepatic failure, consider molecular adsorbent recirculating system (MARS) or "liver dialysis" as a bridge therapy 7.
Pathophysiology and Prognosis
The liver injury is multifactorial 1:
- Direct cocaine hepatotoxicity
- Ischemic injury from hypotension and vasospasm
- Hyperthermia-induced cellular damage
- Prothrombotic effects causing microvascular thrombosis 3
Critical pitfall: Even episodic cocaine use (not just chronic abuse) can cause severe acute liver injury and venous thromboembolism 3. The presence of severe hepatic dysfunction (ALT >400 U/L) identifies patients with potentially life-threatening complications requiring aggressive intervention 1.
Monitoring and Disposition
- Serial liver enzymes every 6-12 hours until trending downward 4
- Daily INR and synthetic function tests 2
- Continuous cardiac monitoring for dysrhythmias 6
- Urine output and renal function given high risk of concurrent AKI 1
Recovery typically occurs with supportive care in survivors, with liver enzymes normalizing over days to weeks 3, 4, 8. However, the 44% mortality rate in severe cases underscores the need for aggressive early intervention 1.